Additionally, miR-194 was demonstrated to regulate DNMT3A expression pattern in drug resistant breast cancer cells and DNMT3A was shown to be the direct target of miR-194 (Le et al. 2010). This evidence concerns the gene DNMT3A and breast carcinoma.